Published in N Engl J Med on July 06, 1989
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction. Semin Immunol (2011) 1.21
Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr Opin Organ Transplant (2011) 1.10
Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg (2010) 1.08
Challenges to achieving clinical transplantation tolerance. J Clin Invest (2001) 1.03
Induction of tolerance through mixed chimerism. Cold Spring Harb Perspect Med (2014) 0.97
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
Development of tolerogenic strategies in the clinic. Philos Trans R Soc Lond B Biol Sci (2005) 0.86
Operational Tolerance in Kidney Transplantation and Associated Biomarkers. Clin Exp Immunol (2017) 0.86
Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation. J Transplant (2013) 0.85
Chimerism-based tolerance in organ transplantation: preclinical and clinical studies. Clin Exp Immunol (2017) 0.84
Current status of renal transplantation. West J Med (1990) 0.81
Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance. Curr Opin Organ Transplant (2015) 0.80
Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes. J Transl Med (2012) 0.77
In vitro assays of allosensitization. Pediatr Transplant (2008) 0.77
Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants. Blood (2016) 0.77
Induction of tolerance in clinical kidney transplantation. Clin Transplant (2010) 0.76
Tolerance in renal transplantation: is mixed chimerism the missing link? Nephrol Dial Transplant (2009) 0.76
The effect of stem cell transplantation on immunosuppression in living donor renal transplantation: a clinical trial. Int J Organ Transplant Med (2013) 0.76
Path to clinical transplantation tolerance and prevention of graft-versus-host disease. Immunol Res (2014) 0.76
Tolerance--is it worth it? Cold Spring Harb Perspect Med (2014) 0.75
Stable mixed chimerism and tolerance to human organ transplants. Chimerism (2016) 0.75
The role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matching. Clin Transpl (1993) 0.75
Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients. Pediatr Nephrol (1995) 0.75
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 8.14
The characterization of soluble amyloid prepared in water. J Clin Invest (1968) 6.17
Polyadenylation sites for influenza virus mRNA. J Virol (1981) 4.42
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med (1996) 4.15
Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations. J Virol (1984) 3.54
The origins of defective interfering particles of the negative-strand RNA viruses. Cell (1981) 3.50
Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A (1996) 3.07
Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med (1974) 3.03
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Site on the vesicular stomatitis virus genome specifying polyadenylation and the end of the L gene mRNA. J Virol (1980) 2.81
Charge distribution as a tool to investigate structural details. II. Extension to hydrogen bonds, distorted and hetero-ligand polyhedra. Acta Crystallogr B (2001) 2.52
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant (2012) 2.46
IRS-2 pathways integrate female reproduction and energy homeostasis. Nature (2000) 2.45
Role of the nucleocapsid protein in regulating vesicular stomatitis virus RNA synthesis. Cell (1985) 2.38
Expression of a cDNA encoding a functional 241-kilodalton vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A (1985) 2.28
Relationship of childhood weight status to morbidity in adults. HSMHA Health Rep (1971) 2.26
The development of subretinal microphotodiodes for replacement of degenerated photoreceptors. Ophthalmic Res (1997) 2.20
Polycistronic vesicular stomatitis virus RNA transcripts. Proc Natl Acad Sci U S A (1980) 2.16
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol (1990) 2.05
The complete sequence of a unique RNA species synthesized by a DI particle of VSV. Cell (1978) 2.04
Location of the binding domains for the RNA polymerase L and the ribonucleocapsid template within different halves of the NS phosphoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1987) 2.03
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med (1999) 2.00
Magnetic brain stimulation with a double coil: the importance of coil orientation. Electroencephalogr Clin Neurophysiol (1992) 1.91
Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved. J Virol (1979) 1.87
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci U S A (2001) 1.85
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer (2008) 1.84
Nature of glomerular dysfunction in pre-eclampsia. Kidney Int (1998) 1.81
A prospective comparison of a percutaneous tracheostomy technique with standard surgical tracheostomy. Intensive Care Med (1991) 1.80
Intervening sequence between the leader region and the nucleopcapsid gene of vesicular stomatitis virus RNA. J Virol (1980) 1.76
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol (2006) 1.74
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles. Cell (1979) 1.72
A comparison of proteinpolysaccharides of bovine nasal cartilage isolated and fractionated by different methods. J Biol Chem (1970) 1.65
The separation of new forms of the proteinpolysaccharides of bovine nasal cartilage. J Biol Chem (1966) 1.61
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy. Ann Oncol (2006) 1.60
Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions. Oral Surg Oral Med Oral Pathol (1994) 1.58
In vivo transcription of the 5'-terminal extracistronic region of vesicular stomatitis virus RNA. J Virol (1981) 1.56
Pathophysiology of congenital diaphragmatic hernia II: the fetal lamb CDH model is surfactant deficient. J Pediatr Surg (1992) 1.55
Few patients with prostate cancer are willing to be randomised to treatment. BMJ (1999) 1.55
Cerebral oxygenation monitoring by near-infrared spectroscopy is not clinically useful in patients with severe closed-head injury: a comparison with jugular venous bulb oximetry. Crit Care Med (1996) 1.51
Visual influence on human locomotion. Modulation to changes in optic flow. Exp Brain Res (1997) 1.47
Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. J Immunol (2001) 1.46
F waves and motor unit size. Muscle Nerve (1992) 1.46
Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med (1993) 1.45
Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys (2001) 1.44
Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. J Exp Med (1986) 1.43
Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation. N Engl J Med (1984) 1.43
Proteinpolysaccharides from human articular and costal cartilage. J Clin Invest (1965) 1.43
Detection of cerebral venous desaturation by continuous jugular bulb oximetry following acute neurotrauma. Anaesth Intensive Care (1995) 1.42
Sites of copy choice replication involved in generation of vesicular stomatitis virus defective-interfering particle RNAs. J Virol (1984) 1.40
Prolonged postpartum course of intrahepatic cholestasis of pregnancy. Gastroenterology (1993) 1.40
Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc Natl Acad Sci U S A (2000) 1.39
Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol (1994) 1.39
The farming crisis. Vet Rec (1999) 1.38
Structure of connective tissues, a chemical point of view. Fed Proc (1966) 1.38
Immunological compatibility between the chacma baboon and man. Transplantation (1991) 1.38
Antibiotic prophylaxis for external ventricular drains in neurosurgical patients: an audit of compliance with a clinical management protocol. Crit Care Resusc (2003) 1.38
The proteinpolysaccharides of bovine nucleus pulposus. J Biol Chem (1967) 1.38
Hyperacute rejection in human-kidney allografts-shwartzman or arthus reaction? N Engl J Med (1969) 1.37
High frequency of submicroscopic genomic aberrations detected by tiling path array comparative genome hybridisation in patients with isolated congenital heart disease. J Med Genet (2008) 1.37
Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L. J Virol (1987) 1.35
The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int (1988) 1.34
Responses of single spinal motoneurons to magnetic brain stimulation in healthy subjects and patients with multiple sclerosis. Brain (1991) 1.32
The interaction of monosodium urate with connective tissue components. J Clin Invest (1970) 1.32
Compliance and use of the World Health Organization checklist in U.K. operating theatres. Br J Surg (2013) 1.31
Cholestatic phenomenon in hepatic allograft rejection in the primate. Transplant Proc (1971) 1.31
Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br (1998) 1.30
The chordate amphioxus: an emerging model organism for developmental biology. Cell Mol Life Sci (2004) 1.26
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med (1996) 1.25
Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity. J Immunol (1992) 1.25
Molecular characterization of the enniatin synthetase gene encoding a multifunctional enzyme catalysing N-methyldepsipeptide formation in Fusarium scirpi. Mol Microbiol (1993) 1.22
Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus. J Immunol (1987) 1.22
Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J Virol (1995) 1.21
Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood (2000) 1.21
Source of cadaver kidneys for transplantation at Johannesburg Hospital. S Afr Med J (1985) 1.20
Ovule and seed development of Lacandonia schismatica (Lacandoniaceae). Am J Bot (1998) 1.20
Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element. J Virol (1995) 1.19
Dendritic cells injected via different routes induce immunity in cancer patients. J Immunol (2001) 1.19
Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions. Neurology (2000) 1.18
The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Curr Alzheimer Res (2009) 1.17
A mutated membrane protein of vesicular stomatitis virus has an abnormal distribution within the infected cell and causes defective budding. J Virol (1987) 1.16
Phenotypic characterization of collagen gel embedded primary human breast epithelial cells in athymic nude mice. Cancer Lett (1994) 1.16
Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant (2015) 1.15
Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type I diabetes. Trans Assoc Am Physicians (1984) 1.15
Diagnosis and management of lymphoceles after renal transplantation. Urology (1977) 1.15
Glyceraldehyde-3-phosphate dehydrogenase gene diversity in eubacteria and eukaryotes: evidence for intra- and inter-kingdom gene transfer. Mol Biol Evol (1999) 1.14
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 1.14
AmphiPax3/7, an amphioxus paired box gene: insights into chordate myogenesis, neurogenesis, and the possible evolutionary precursor of definitive vertebrate neural crest. Evol Dev (2001) 1.13
A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. AIDS Res Hum Retroviruses (1998) 1.13
The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab (1983) 1.13
Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury. Spinal Cord (2010) 1.12
Non-destructive and quantitative imaging of a nano-structured microchip by ptychographic hard X-ray scanning microscopy. J Microsc (2011) 1.12
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Am J Med (1986) 1.11
Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J Exp Med (1998) 1.11
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study. Leukemia (2002) 1.11